Staph infection drug dosing under the microscope: new study aims for precision

NCT ID NCT06848387

Recruiting now Knowledge-focused Sponsor: Emeli Månsson Source: ClinicalTrials.gov ↗

First seen Mar 04, 2026 · Last updated May 23, 2026 · Updated 12 times

Summary

This study looks at how much cloxacillin is available in the blood when given as a continuous infusion to adults with serious staph infections. Researchers will measure the free (unbound) drug concentration to make sure it is not too high or too low. They will also create a model to predict the right dose for each person based on age, gender, kidney function, and protein levels. About 25 adults whose doctors have already decided to start this treatment will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STAPHYLOCOCCAL INFECTIONS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-••••

Locations

Västmanlands sjukhus Västerås
RECRUITING

Västerås, Sweden

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

STAPHYLOCOCCAL INFECTIONS